EKSO Q2 2025 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$29M

Q2 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$2M-58.4% YoY

Gross Profit

$819,00039.8% margin

Operating Income

-$4M-193.2% margin

Net Income

-$3M-131.7% margin

EPS (Diluted)

$-1.24

QoQ Revenue Growth

-39.1%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$207,000

Balance Sheet

Total Assets

$23M

Total Liabilities

$12M

Stockholders' Equity

$11M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$5M	-58.4%
Gross Profit	$819,000	$3M	-68.9%
Operating Income	-$4M	-$2M	-70.2%
Net Income	-$3M	-$2M	-12.1%

Geographic Segments

Americas

$1M25%

UNITED STATES

$1M25%

EMEA

$978,00024%

Other Country

$613,00015%

FRANCE

$365,0009%

APAC Other

$40,0001%

Asia Pacific

$40,0001%

Americas Other

$16,0000%